Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 16,417 | 14,757 | 15,675 | 15,704 | 15,532 |
| Cost of Goods | 1,777 | 1,444 | 1,517 | 1,357 | 1,154 |
| Gross Profit | 14,640 | 13,313 | 14,158 | 14,347 | 14,378 |
| Operating Expenses | 17,638 | 16,498 | 18,265 | 17,290 | 17,939 |
| Operating Income | -2,998 | -3,185 | -4,107 | -2,943 | -3,561 |
| Interest Expense | 1,930 | 1,913 | 1,951 | 1,827 | 1,737 |
| Other Income | -4,392 | -734 | -466 | 269 | -3,848 |
| Pre-tax Income | -9,320 | -5,832 | -6,524 | -4,501 | -9,146 |
| Income Tax | 117 | -40 | -95 | -91 | -3 |
| Net Income Continuous | -9,437 | -5,792 | -6,429 | -4,410 | -9,143 |
| Net Income | $-9,437 | $-5,792 | $-6,429 | $-4,410 | $-9,143 |
| EPS Basic Total Ops | -0.29 | -0.18 | -0.20 | -0.14 | -0.28 |
| EPS Basic Continuous Ops | -0.29 | -0.18 | -0.20 | -0.14 | -0.28 |
| EPS Diluted Total Ops | -0.29 | -0.18 | -0.20 | -0.14 | -0.28 |
| EPS Diluted Continuous Ops | -0.29 | -0.18 | -0.20 | -0.14 | -0.28 |
| EBITDA(a) | $976 | $4,400 | $4,119 | $6,160 | $1,080 |